GTS Securities’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-13,100
Closed -$192K 2099
2024
Q3
$192K Sell
13,100
-600
-4% -$8.36K ﹤0.01% 3661
2024
Q2
$198K Sell
13,700
-84,000
-86% -$1.34M ﹤0.01% 3458
2024
Q1
$1.59M Buy
97,700
+16,400
+20% +$256K ﹤0.01% 1639
2023
Q4
$1.21M Buy
81,300
+64,900
+396% +$735K ﹤0.01% 2015
2023
Q3
$184K Buy
+16,400
New +$190K ﹤0.01% 3444

Other funds holding ELAN

GTS Securities's ELAN Position: Q4 2024 in Review

GTS Securities sold out of Elanco Animal Health (ELAN) in Q4 2024, closing a stake of 81,201 shares — an estimated $1.19M sold.

GTS Securities first reported a position in ELAN in Q2 2023 and held it in 6 quarters. The position peaked at $1.86M in Q4 2023. 393 funds tracked by Wall St. Rank hold ELAN as of Q4 2024.

  • GTS Securities reported no remaining Elanco Animal Health position as of Q4 2024 after selling out during the quarter.
  • GTS Securities sold 81,201 Elanco Animal Health shares in Q4 2024, an estimated $1.19M.
  • GTS Securities first reported a position in Elanco Animal Health in Q2 2023 and held it in 6 quarters.
  • GTS Securities's Elanco Animal Health position peaked at $1.86M in Q4 2023.
  • 393 funds tracked by Wall St. Rank held Elanco Animal Health as of Q4 2024.

Based on GTS Securities's 13F filing for Q4 2024, filed 18 Feb 2025.